Stock earnings page

Agios Pharmaceuticals, Inc. (AGIO)

Track the next or latest earnings date for Agios Pharmaceuticals, Inc., review consensus estimates, and see cached AI analysis for recent quarterly results.

View this earnings week Open in the app

Recent earnings news

Here's Why Agios Pharmaceuticals Stock Soared Today (Hint: It's FDA-Related) | The Motley Fool
fool.com · 3 hours ago

The company received some good news on its most important drug today.

The Technical Signals Behind (AGIO) That Institutions Follow - Stock Traders Daily
news.stocktradersdaily.com · 2 days ago

Price-action only: Agios Pharmaceuticals Inc. (AGIO) movements set the tone for institutional models. The Technical Signals Behind (AGIO) That Institutions Follow

SPCX Stock Slides Ahead Of Nasdaq-100 Debut: Billionaire Value Investor Says Its ‘Third-Rate’ AI Is Getting ‘Kicked Around’ By Anthropic, OpenAI
stocktwits.com · 12 hours ago

AGIO Stock Hits Over 7-Month Highs – FDA Catalyst, ‘Seasonally Strong’ Q2 Earnings Estimate Drive Optimism

Agios Pharmaceuticals, Inc. Stock 12‑Month Price Target Raised to $42.62, Implies 14% Upside
tradingview.com · 6 hours ago

Explore more price target data and ratings for Agios Pharmaceuticals, Inc. on the Forecasts tab, and track all previous and future analyst recommendations for Agios Pharmaceuticals, Inc. in the dedicated News Flow.Select reference data provided by FactSet. Copyright © 2026 FactSet Research ...

Agios Pharmaceuticals Stock Rises 12% After FDA Grants Priority Review For Sickle Cell Drug
rttnews.com · 5 hours ago

Shares of Agios Pharmaceuticals, Inc. (AGIO) gained more than 12% on Tuesday morning after the U.S. Food and Drug Administration granted Priority Review to the company's supplemental New Drug Application (sNDA) for mitapivat in sickle cell disease.

Latest earnings date

Feb 12, 2026

Time not specified

Fiscal quarter: Dec/2025

EPS estimate: -$1.97

Revenue estimate: N/A

Market cap: $1.57B

Analysis snapshot

No cached AI earnings analysis is available for this stock yet. Check back after the company reports or open the app to generate a fresh analysis.

Recent earnings history

Browse the calendar week

Date	Quarter	Report window	EPS est.	Revenue est.
Feb 12, 2026	Dec/2025	Time not specified	-$1.97	N/A